Insulin Detemir
Indication
Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above
Green
Brand:
Levemir ®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
Must be commenced by a healthcare professional who is appropriately trained and experienced in the initiation of insulin.
Insulin Detemir (Levemir®) is supported for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above. Recommendation: Green
Appropriate for initiation and ongoing prescribing in both primary and secondary care. Monitoring is required but this is routine monitoring required for all insulin's.
The LSCMMG recommends Levemir FlexPen® as the 2nd line long-acting insulin analogue (1st line — Abasaglar KwikPen®).
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: